Sinopharm
1099.HK
$2.54
Share price
-1.78%
Change (1 day)
-28.25%
Change (1 year)
Categories
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.
Sinopharm (1099.HK) - Cash on Hand
Cash on Hand as of June 2023 : $4.74 B
According to Sinopharm's latest financial reports the company has $4.74 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Sinopharm - Cash on Hand chart (from 2008 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $9.75 B | 42.72% |
| 2021-12-31 | $6.83 B | -11.25% |
| 2020-12-31 | $7.69 B | 37.24% |
| 2019-12-31 | $5.61 B | -4.35% |
| 2018-12-31 | $5.86 B | 17.72% |
| 2017-12-31 | $4.98 B | 35.27% |
| 2016-12-31 | $3.68 B | 19.56% |
| 2015-12-31 | $3.08 B | 25.23% |
| 2014-12-31 | $2.46 B | 6.32% |
| 2013-12-31 | $2.31 B | 47.16% |
| 2012-12-31 | $1.57 B | -24.52% |
| 2011-12-31 | $2.08 B | 84.25% |
| 2010-12-31 | $1.13 B | 2.03% |
| 2009-12-31 | $1.10 B | 277.85% |
| 2008-12-31 | $0.29 B | 9.38% |
| 2007-12-31 | $0.26 B | 13.82% |
| 2006-12-31 | $0.23 B |